MedTech start-up XO Life, with offices in Berlin and Munich, has recently raised more than €2 million in funding to further develop its Patient Insights platform, which was originally conceived as a leading platform for reporting and providing information on side effects of medications and therapies. The expanded platform aims to provide patients with a way to record their experiences with their health, medications and conditions in a standardized and privacy-compliant way. These so-called Patient-Reported Outcomes (PROs) can then be compared with the experiences of other users and made available to the healthcare industry in anonymized form.
The company is working closely with Charité's PROMIS Institute Germany and various pharmaceutical manufacturers to make the recording of patient experience on its platform a standard in healthcare. The latest funding round was supported by various investors, including the international healthcare VC SeedLink, the corporate VC MediVentures, Aescuvest and other healthcare technology service providers. Dr. Friderike Bruchman, Co-Founder & CEO of XO Life, was positive about the collaboration with the new shareholders and emphasized that their platform will set a benchmark in the direct collection of patient insights in the real care setting and enable both patients and all healthcare stakeholders to participate.
